ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG); Drug: Granulocyte colony stimulating factor (GCSF); Drug: Placebo (for ATG); Drug: Placebo (for GCSF)
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR); Juvenile Diabetes Research Foundation; American Diabetes Association; Sanofi; The Leona M. and Harry B. Helmsley Charitable Trust; Amgen
Active, not recruiting - verified July 2016
Interventions: Drug: Anti-Thymocyte Globulin (ATG); Drug: Granulocyte colony stimulating factor (GCSF); Drug: Placebo (for ATG); Drug: Placebo (for GCSF)
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Research Resources (NCRR); Juvenile Diabetes Research Foundation; American Diabetes Association; Sanofi; The Leona M. and Harry B. Helmsley Charitable Trust; Amgen
Active, not recruiting - verified July 2016
News Type: